Viprinex

Viprinex™

Ancrod, formerly Arvin™ Critical care An orphan drug from Malayan pit viper venom, used in Pts with acute ischemic stroke to anticoagulate heparin-intolerant Pts undergoing CABG. See CABG.
References in periodicals archive ?
Obvious examples include insulin, which in its earliest, nonsynthetic form was manufactured from the pancreatic enzymes of pigs and calves, Primarin, an estrogen derived from pregnant mare's urine, and the anticoagulant Viprinex, which uses the venom of the Malaysian pit viper.
Beastly physic
today announced the completion of a snake facility in Moorrege, Germany, that will provide the venom used to produce Viprinex, which NTI is currently studying as a potential treatment for acute ischemic stroke.
Viprinex (Ancrod) is currently being studied in two Phase III global trials known as Ancrod Stroke Program I (ASP-I) and Ancrod Stroke Program II (ASP-II).
Neurobiological Technologies Inc. Completes 'Snake' Facility for Venom Used as Stroke Treatment
Baxter will aseptically fill and package the drug product, Viprinex, into its finished form, along with the corresponding placebo.
NEUROBIOLOGICAL TECHNOLOGIES SIGNS VIPRINEX PACTS
If pivotal Phase III trials for Viprinex are commenced as currently planned, NTI will issue an additional 2,375,176 shares and pay an additional $2 million to the Empire stockholders.
Additionally, we are currently designing clinical trial protocols for what we expect to be pivotal Phase III clinical trials for our newest product, Viprinex (ancrod), for the treatment of ischemic stroke.
NEUROBIOLOGICAL REPORTS 4TH QTR NET LOSS OF $1,O15,000
Medical browser ?
Full browser ?